SEC Comment Letter 0000000000-24-006817 to BIO-PATH HOLDINGS, INC. (BPTH)
BIO-PATH HOLDINGS, INC.
Date: June 13, 2024 · CIK: 0001133818 · Accession: 0000000000-24-006817
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280130
Letter
United States securities and exchange commission logo June 13, 2024 Peter H. Nielsen President and Chief Executive Officer Bio-Path Holdings, Inc. 4710 Bellaire Boulevard, Suite 210 Bellaire, Texas 77401 Re:Bio-Path Holdings, Inc. Registration Statement on Form S-3 Filed June 11, 2024 File No. 333-280130 Dear Peter H. Nielsen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William R. Rohrlich, II
Show Raw Text
United States securities and exchange commission logo
June 13, 2024
Peter H. Nielsen
President and Chief Executive Officer
Bio-Path Holdings, Inc.
4710 Bellaire Boulevard, Suite 210
Bellaire, Texas 77401
Re:Bio-Path Holdings, Inc.
Registration Statement on Form S-3
Filed June 11, 2024
File No. 333-280130
Dear Peter H. Nielsen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: William R. Rohrlich, II